NIH unit awards $6.5M grant to Dana-Farber for vaccine research

08/15/2010 | Mass High Tech (Boston)

The National Institute of Allergy and Infectious Diseases, a division of the NIH, has awarded a $6.5 million grant to Dana-Farber Cancer Institute to help it develop a universal T cell-based vaccine against influenza A viruses. "Our ultimate goal is a vaccine that targets the conserved viral segments that cannot vary from one viral strain to another, thereby providing protection against all seasonal and pandemic flus," said Ellis Reinherz, the study's principal investigator.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN